Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-09-05 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司2024年第四次临时股东大会通知
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed notice about convening the 2024 fourth extraordinary general meeting of shareholders for 南微医学科技股份有限公司. It includes information about the meeting date, voting methods, agenda items (such as election of non-independent directors), registration procedures, and proxy forms. There is no financial data, earnings, audit information, or report publication mentioned. The document is not a report itself but a formal announcement and notice for a shareholders meeting, including voting instructions and agenda details. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than the solicitation materials or proxy statement, it is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) because it relates to the voting process and agenda for the shareholder meeting. The document length is under 5,000 characters, but it is not merely announcing a report publication; it is a full notice of the shareholder meeting and voting details. Therefore, the best fit is DVA.
2024-09-05 Chinese
南微医学科技股份有限公司关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, the price range, total amount spent, and compliance with relevant regulations. It does not contain financial statements or earnings data, nor is it a report or presentation. The document is specifically about the company's buyback of its own shares, which fits the category of Transaction in Own Shares (POS). The document length is short and focused solely on share repurchase progress, confirming it is not a full financial report or announcement of a report publication.
2024-09-03 Chinese
南微医学科技股份有限公司2024年第三次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled '2024 年第三次临时股东大会会议资料' which translates to '2024 Third Extraordinary General Meeting (EGM) Meeting Materials'. It contains detailed information about the meeting agenda, voting procedures, shareholder rights, and a specific proposal regarding the 2024 half-year profit distribution plan. The content is clearly meeting materials prepared for a shareholders' meeting, including instructions, agenda, and proposals to be voted on. It is not a report itself (like an annual or interim report), nor is it a brief announcement or voting results. It fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during a general meeting. Although this is an extraordinary general meeting (not annual), the closest category is AGM Information (AGM-R) as it covers meeting materials. The document length is 4082 characters, which is consistent with detailed meeting materials rather than a short announcement or a full report. Therefore, the classification is AGM-R with high confidence.
2024-08-30 Chinese
南微医学科技股份有限公司2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2024 年半年度报告摘要" which translates to "2024 Semi-Annual Report Summary." It contains financial data for the half-year period, including total assets, net profit, earnings per share, and other financial metrics. It also includes shareholder information and dividend distribution plans. The document explicitly states it is a summary of the half-year report and advises investors to read the full report on the official website. The document length is 3155 characters, which is relatively short, but it contains substantive financial data and analysis for the half-year period, not just an announcement or a link to a report. Therefore, it qualifies as an Interim / Quarterly Report (IR).
2024-08-22 Chinese
南微医学科技股份有限公司关于2024年半年度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2024 semi-annual profit distribution plan of the company 南微医学科技股份有限公司. It details the dividend per share, the total dividend amount, the basis for calculation, and the approval process including board and supervisory committee meetings. It explicitly states the dividend distribution plan and the need for shareholder meeting approval. The document is relatively short (1520 characters) and focuses on dividend distribution details rather than presenting full financial statements or comprehensive financial analysis. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related details for shareholders.
2024-08-22 Chinese
南微医学科技股份有限公司2024年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2024 年半年度募集资金存放与使用情况的专项报告" which translates to "2024 Semi-Annual Special Report on the Deposit and Use of Raised Funds." It details the amount of funds raised, their usage, balances, management, and compliance with regulatory requirements. The document includes specific financial figures related to fundraising, usage of funds, and investment projects, and it is a comprehensive report for a half-year period (2024 semi-annual). The content focuses on the management and use of capital raised by the company, which aligns with a Capital/Financing Update. It is not a full annual or interim financial report, nor is it an announcement or certification. The length and detail confirm it is a substantive report on fundraising and capital usage for the half-year period.
2024-08-22 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.